Drugs / Gcsf
last change Jan 2023 re-read 2 minutes ago

Gcsf

Developed for
chronic granulomatous disease
Investigated by
Federal Research Institute of Pediatric Hematology, Oncology and Immunology

Trials 1 · a red edge is where a trial was stopped

2020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT03547830 Apr 2019 → Jan 2023 chronic granulomatous disease Federal Research Institute of Pediatric Hematology, Oncology and Immunology Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as GCSF GCSF for Conditioning before HSCT.” NCT03547830
1

NCT03547830